12:00 AM
Sep 09, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Fate Therapeutics amends IPO

Fate Therapeutics Inc., San Diego, Calif.
Business: Gene/Cell therapy, Cancer, Musculoskeletal
Date announced: 9/3/13
Type: IPO

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >